Pharmafile Logo

ReSearch Pharmaceutical Services

RPS provides comprehensive global Phase I-IV clinical development solutions to the Pharmaceutical, Biotechnology, Medical Device and Diagnostic industries. The company has operations in 45 countries across Europe, the Americas, Asia-Pacific and Africa.

This is a FREE LISTING on PMHUB

Below are full profiles from other companies in related areas

Havas Life London

We are a fully integrated agency that is 100% dedicated to creating standout communications in healthcare. Our success starts by strategically aligning promotion, medical education and PR across the product…

View Profile

Sciterion

Sciterion is an award winning specialist healthcare communications consultancy within the Havas Health network of companies. We exist to make a positive contribution to patient care. Real world experience of…

View Profile

Streaming Well

Streaming Well is a healthcare-focused, award-winning video production company which operates in the US and Europe. We create engaging visual stories and interactive experiences that connect with people.

View Profile

Uniphar

Uniphar Group is a trusted global partner to pharmaceutical, medtech, and supply chain and retail companies, working to improve patient access to medicines around the world.

View Profile

Company Details

520 Virginia Drive, Fort Washington, PA 19034, USA
+1 215 540 0700

 Latest Content from PMHub 

White paper: Are we prepared for the influx of CAR-Ts?

Download this white paper, in which we look at how market access and hospital processes will need to transform to accommodate the the influx of CAR-T therapies

Shining a light on rare diseases with ‘Noah’s Story’

In recognition of Rare Disease Day, Bedrock share 4 minutes of a true story you won’t want to miss.

Accession welcomes Graham Ridgway as Non-Executive Chairman

Press Releases | February 25, 2022 | Accession

Accession, a specialist pharma market access consulting and software company, announces the appointment of accomplished software CEO Graham Ridgway as Non-Executive Chairman.

Rare Disease Day – looking to the future with hope

Press Releases | February 25, 2022 | Nucleus Global

On this year’s Rare Disease Day, Amanda Henkel, VP, Strategy, Nucleus X Consulting (part of Nucleus Global), reflects on recent advances in the rare disease setting.

Bridging the gender health gap: 9 key takeaways from Thrive’s webinar on tech and women’s health

Press Releases | February 25, 2022 | Thrive Agency

Unequal health outcomes have been a reality for women throughout the world for far too long. But change is finally happening.

Bedrock to raise awareness of Rare Disease Day 2022 with film ‘Noah’s Story’

Emily Wigginton, Bedrock’s Head of Client Services explains the inspiration behind the film.

Eating Disorders Awareness Week

In the latest blog post, Innovative Trials' Equality & Diversity committee focuses on eating disorders

Social Health Prescription: Connecting People, Empowering Patients, & Improving Outcomes

Videos and Podcasts | February 25, 2022 | Impetus Digital

Lynda Brown-Ganzert, Founder & CEO of Curatio, discusses the concept of social health prescription and the inspiration behind Curatio. She also explores questions such as how AI and “intelligent matchmaking” can be leveraged...

A Lucid Group social

The newly formed Lucid Social Committee is launching its first event for the year: Today, on Thursday 24 February Lucid will be hosting its inaugural board games night in both...

Welcome to the era of the orphan drug

As we approach Rare Disease Day on 28 February, we look back at how the rare disease landscape has evolved over the last few decades.